Cost-effectiveness of PCV13 vaccination in Belgian adults aged 65-84 years at elevated risk of pneumococcal infection

PLoS One
http://www.plosone.org/
[Accessed 7 Jul 2018]

Research Article
Cost-effectiveness of PCV13 vaccination in Belgian adults aged 65-84 years at elevated risk of pneumococcal infection
Sophie Marbaix, Willy E. Peetermans, Jan Verhaegen, Lieven Annemans, Reiko Sato, Annick Mignon, Mark Atwood, Derek Weycker
Research Article | published 06 Jul 2018 PLOS ONE
https://doi.org/10.1371/journal.pone.0199427